ArticleScientific reports2025
An integrated approach for rare disease detection and classification in Spanish pediatric medical reports.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Capsule-enhanced hierarchical vision transformers for rare disease classification from medical images.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Rare disease detection and classification is one of the most significant challenges in the application of Natural Language Processing techniques to the analysis and extraction of information from biomedical texts. In this paper, we present a novel research focused on the detection and classification of rare diseases in clinical notes extracted from a cohort of pediatric patients from the Community of Madrid in Spain. From a set of collected and anonymized medical records, we propose a semi-supervised, keyphrase-based system to perform an initial detection of mentions of rare diseases, which is then validated and refined by experts to build a consolidated dataset concerning a subset of different rare diseases. Based on this dataset, we carry out a series of experiments for rare disease classification using both a semi-supervised technique and state-of-the-art supervised systems based on both discriminative and generative models. A detailed case analysis provides insights on which systems excel in specific scenarios and why. The validated dataset contains a total of 1900 annotated texts containing mentions to rare diseases. Experiments on this dataset show that the best supervised models improve the performance of the semi-supervised system by more than 10% (78.74% vs 67.37% micro-average F-Measure), individually enhancing the classification of a significant number of diseases in the dataset. State-of-the-art supervised systems are able to offer promising results on the detection and classification of rare diseases in clinical texts, even in cases for which the amount of annotated information is low. On the other hand, semi-supervised models present interesting capabilities for dealing with limited information and data in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.